medicine

23°

Weather

YnetGlobal Channels

Sites & Sources

more channels

Contact

medicine

Immunai expands AstraZeneca collaboration in deal worth up to $37.5 million

New York-based AI biotech firm says AstraZeneca will keep using its AMICA-OS platform for oncology drug development under expanded collaboration running through 2027

ynet Global | 05.08.26

Drug boom: Lebanon’s war-weary population turns to sedatives in droves

Pharmacists report requests for sleeping pills and sedatives soaring over 300% as war, displacement and years of crisis deepen anxiety, though officials say orders may partly reflect stockpiling rather than actual use

Lior Ben Ari | 05.07.26

Israeli biotech firm MSICS raises $3.6M to push psychedelic therapy into trials

MSICS Pharma says funds will expand production, speed clinical trials for PTSD, depression and OCD, and prepare its psilocybin product for global markets

ynet Global | 05.05.26

It's not 'all in your head': women’s neurology is reshaping how doctors understand the brain

Medicine is only beginning to grasp how brain diseases differ in women; Dr. Tal Friedman-Koren is training in women’s neurology, an emerging field challenging decades of assumptions about diagnosis, symptoms and treatment

Eitan Gefen | 04.23.26

Uzbek-born doctor leaves quiet life behind to serve as IDF combat medic

After building a medical career in Tashkent, Lt. S. immigrated to Israel with his family in 2023, retrained in Hebrew and enlisted during the war — a journey he says turned service to wounded soldiers into a calling and Israel into home

Eitan Gefen | 04.22.26

The drugs that almost work: why the biggest breakthroughs still fail

As drug developers grapple with partial efficacy and uneven patient response, Tel Aviv-based biotech company Immunai is building an AI-powered immune atlas to explain how therapies work in the body

ynet Global | 04.09.26

Dimer Health raises $13.5 million to expand AI-driven post-discharge care

The Series A round, led by Team8 and Bill Ackman’s Table Management, will help the company expand its physician-led transitional care model across the US as it seeks to reduce readmissions during the critical weeks after hospital discharge

ynet Global | 03.25.26

Etihad Airways plane; airports in the UAE were damaged and suffered heavy disruptions

War disrupts medicine supply routes, raising concerns over cancer treatment delays

War disrupts key Middle East air hubs, forcing rerouting of temperature-sensitive drug shipments; health officials warn prolonged delays could affect cancer treatment supplies

Tzur Gueta | 03.17.26

Graphic abstract (from bottom left, clockwise): Muscle tissue containing mature cells and vascular networks; fat tissue containing blood vessels and lymphatic networks; printing of these flaps; and immediate perfusion of the flap by the host tissue

Technion team develops 3D implant that mimics lost human tissue

The bioengineered flap combines muscle, fat, blood vessels and, for the first time, a lymphatic network in a single structure, offering a potential future alternative for patients with severe tissue loss from burns, injuries or tumor removal

ynet Global | 03.15.26

Gil Hakim, CEO of Matricelf, and Lee Buckler, Vice President, Advanced Therapies Blood Centers of America

Israeli biotech firm Matricelf wins innovation award at San Diego conference

The Ness Ziona-based company was recognized at Advanced Therapies Week 2026 for its personalized spinal cord implant as it prepares to seek approval for human clinical trials

ynet Global | 02.16.26

Used to swallowing pills? smarter ways to take vitamins and medications

New 'delivery systems' protect vitamins and medications and improve absorption, with options including liquids, soft gels, powders and sprays; how do you choose the right one?

Roy Rothenberg | 02.13.26

מימין לשמאל: האלוף במיל' רם רוטברג, מייסד מסע אל האופק, המנטור אלון שחק, אביו של מיכאל פז ומיכאל הזוכה

Combat veteran’s MedTech startup wins top prize for revolutionizing patient intake

Patients enter structured medical information — symptoms, history and background — in advance, while the system delivers a ready clinical summary to doctors before the visit; the project won at OfekTech, the tech accelerator for army and national service alumni of Masa El HaOfek

ynet | 02.10.26

When medical journals become platforms for political messaging: The Lancet and Gaza

Opinion: Recent Gaza coverage by the British medical journal The Lancet highlights a shift from scientific inquiry to moral advocacy, raising concerns about bias, editorial framing and the erosion of academic neutrality in politically charged contexts

Dr. Daniel Radzik | 02.01.26

זוכה הנובל פרופ' יואל מוקיר בדיון בעזיבת רופאים בכנס ScienceAbroad במיאמי

‘Unimaginable gaps in pay’: doctors warn of deepening medical exodus from Israel

Dr. Gabriel Levin, a senior gynecologic oncologist with 320 published papers, left Hadassah for Canada four years ago but will return this summer despite lucrative offers, as a ScienceAbroad conference in Miami highlighted a deepening crisis; Nobel laureate Prof. Joel Mokyr warns Israel is ‘losing the next generation’

Itamar Eichner | 01.19.26

Israeli investor closes $100 million fund focused on next-generation biotech therapies

The new Bio Ventures III fund lifts Arkin Bio’s assets under management above $600 million and will target early-stage biotech companies worldwide developing treatments for cancer, rare diseases and other high unmet medical needs

Maayan Hoffman | 01.17.26

Hot Tags

Today

This Week

This Month

Judicial reform Ahmad al-Sharaa Airstrike Amsterdam Antisemitism Ariel Bibas Benjamin Netanyahu Bitcoin Climate crisis Columbia University

Hot Tags

Today

This Week

This Month

Judicial reform Ahmad al-Sharaa Airstrike Amsterdam Antisemitism Ariel Bibas Benjamin Netanyahu Bitcoin Climate crisis Columbia University